Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
  • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/0216—Solid or semisolid forms
  • A61K8/022—Powders; Compacted Powders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/0241—Containing particulates characterized by their shape and/or structure
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
  • A61K8/88—Polyamides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
  • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
  • C08G69/46—Post-polymerisation treatment
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
  • C08J3/00—Processes of treating or compounding macromolecular substances
  • C08J3/12—Powdering or granulating
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
  • C08J3/00—Processes of treating or compounding macromolecular substances
  • C08J3/12—Powdering or granulating
  • C08J3/14—Powdering or granulating by precipitation from solutions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/52—Stabilizers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/60—Particulates further characterized by their structure or composition
  • A61K2800/65—Characterized by the composition of the particulate/core
  • A61K2800/654—The particulate/core comprising macromolecular material
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
  • C08J2377/00—Characterised by the use of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Derivatives of such polymers

Definitions

• the invention relates to a polyamide powder suitable for cosmetic applications which has a defined pH in aqueous suspension, and to the preparation thereof.
• Polyamide fine powders are used in numerous cosmetic products, such as, for example, in lipsticks, make-ups, powders and creams. They generally comprise fine powders based on polyamide 11 and/or polyamide 12, and also polyamide 6 and PA6/12 copolymers having an average particle diameter of from 5 to 30 ⁇ m. Polyamide powders with a larger average particle diameter of up to 400 ⁇ m are used, inter alia, in shower gels to achieve a peeling effect.
• powders from both processes frequently have, as a result of their respective preparation process, a pH which is outside the range which is regarded by dermatologists as the optimum pH range for the acid protective mantle of the skin.
• a pH which is either too acidic or too basic can lead to skin irritations.
• a basic pH also causes the skin to dry out. As a result, the skin becomes brittle and its elasticity decreases. In addition, under stress, cracks and small skin injuries may rapidly result.
• an anionically activated polymerization of monomeric lactam, preferably laurolactam takes place in higher-boiling paraffins (140 to 170° C.). Strongly basic catalysts are used for this purpose, as a result of which such fine powders usually have a slightly basic/alkaline reaction despite repeated washing. The pH values of such powders are between 7 and 8.5.
• the fine powders obtained from both processes have a round particle shape. Powders from the two processes are usually protection-screened and/or sifted and may optionally be subsequently ground to increase the proportion of fines.
• Most cosmetic preparations generally comprise only between 0.1 and 10% by weight of polyamide fine powder. Depending on the field of use, the remainder consists of a variety of oils, fats, emulsifiers, stabilizers, and also dyes and aroma substances. They usually comprise a sufficiently large buffer system in order to produce a cosmetic application with a skin-friendly pH.
• polyamide powders as described in the claims, in particular precipitated powders, polyamide powders which have been prepared according to the precipitation process, can be well regulated if they are equipped with a special buffer system.
• This buffer system is based here preferably on naturally occurring acids and their corresponding salts.
• the slightly basic polyamide powder can also be buffered using the process according to the invention.
• this pH is from 4 to 7.
• This polyamide powder is achieved by adding a buffer system to the polyamide powder.
• Another embodiment of the invention is a cosmetic composition containing the polyamide powder with the specified pH and a carrier
• Suitable polyamide powders are, in particular, powders which have polyamide 11 and/or polyamide 12. Particular preference is given to a polyamide 12 precipitated powder with porous surfaces, as arise in accordance with DE 29 06 647 B1.
• the polyamide powder according to the invention has an average particle size diameter (d 50 ) of from 1 to 400 ⁇ m, preferably 5 to 100, particularly preferably 5 to 60.
• buffer system is understood to mean the combinations of weak organic and/or mineral acids and their corresponding salts.
• naturally occurring acids are understood to mean organic and/or mineral compounds which are either formed in the human body itself or are frequently taken in by humans, for example with food or via the skin, without resulting, as far as is known, in any damage to health. It is also important here that the compounds can be degraded completely by the human organism and that, as far as is known, neither the compounds themselves which have been taken in, nor their metabolites, lead to health damage.
• the buffer system is based on natural organic and/or inorganic acids, i.e. acids which occur in the human body, and salts thereof. Examples of which are phosphate buffer and/or citrate buffer.
• Salts which can be used include all bases corresponding to the abovementioned acids.
• use is usually made of physiologically safe alkali metal and alkaline earth metal salts, and ammonium salts, although other cations are also possible.
• the term “acid” also covers the corresponding hydrogen salts of polybasic acids, for example sodium dihydrogenphosphate or disodium hydrogencitrate.
• a pH of from 4 to 7 is generally recommended by dermatologists in order to avoid irritations or drying out of the skin.
• Particular preference is given to a pH range of from 4.5 to 6.5, and more particularly from 5.0 to 6.0.
• a concrete “optimum” pH of the skin cannot generally be given. It differs from person to person, possibly due to the respective skin type. It also depends on the sex and age of the person in question (see, inter alia, Rompp Chemielexikon, 9th edition, p. 1743).
• Citric acid [0026] Citric acid:
• a suitable buffer is the pKa 3 value, i.e., for example, the disodium hydrogencitrate/trisodium citrate system.
• phosphoric acid it is the pKa 2 value, for example in the form of the sodium dihydrogenphosphate/disodium hydrogenphosphate system.
• the content of buffer system in the cosmetic powder should be kept as low as possible.
• the cosmetic properties of the polyamide powder should also be influenced as little as possible by the content of buffer system. At the same time, however, an adequate buffer capacity should be achieved in order to be able to maintain the desired pH in the cosmetic powder.
• the content of acid and base functions in the polyamide refers both to the carboxyl and amino end-groups of the polyamide chains and also to acidic or basic added substances which have functioned during the polymerization as catalyst (e.g. phosphorus-containing acid) or as regulator (e.g. dodecanedioic acid).
• catalyst e.g. phosphorus-containing acid
• regulator e.g. dodecanedioic acid
• the content of acid and amino functions in the polyamide can be readily quantified, for example, by titrimetric methods. These are generally known and can be found, for example, in Kunststoff-Handbuch, volume 3, 4 “Polyamide”, HanserVerlag, Kunststoff.
• the free acid in the buffer component can be reduced or in some cases omitted entirely.
• the corresponding base in the buffer can be reduced accordingly.
• the buffer system comprising acid and corresponding base, is chosen so that as a rule there are 0.001 to 10 parts of the buffer per 100 parts of polyamide, preferred limits being 0.01 to 2 parts of the buffer system per 100 parts of polyamide, and more preferably 0.1 to 1 parts of the buffer system per 100 parts of polyamide.
• the buffer system can be incorporated into the polyamide according to the invention via various processes.
• buffer system and polyamide powder are mixed dry and intimately.
• a prerequisite for this is that the ground buffer system does not have a significantly larger average particle diameter than the respective polyamide fine powder.
• the buffer system is first ground as fine as possible in the dry state, so that the average particle diameter is significantly lower than the average diameter of the polyamide particle. The buffer system can then penetrate upon mixing into the pores of the polyamide particle.
• porous polyamide precipitated powders are particularly suitable.
• polyamide fine powders with an average particle diameter d 50 of less than 20 ⁇ m, it is advisable that polyamide powder and the buffer system are firstly mixed together and then ground and sifted in a common step to the desired particle size.
• the buffer system can also attach to the polyamide particles in solution.
• This process can be used for all polyamide powders.
• a precipitated powder such as VESTOSINT
• This step can in this case also be integrated in a combined mixer/dryer directly in the precipitation process. Time can be saved if the drying of the polyamide powder from the precipitation process and incorporation of the buffer system take place in the same container, which can also reducing processing to one step.
• the buffer system dissolved in a solvent, can also be sprayed onto the polyamide particles.
• Suitable solvents are include water and/or aqueous-alcoholic solutions. The solvent is then stripped off completely at elevated temperatures in the mixer, and/or under vacuum.
• the increased temperatures in the mixer have the effect that in this process the buffer system is present in very finely and uniformly dispersed form on the polyamide particle, and the free carboxyl and amino end-groups in the polyamide have already chemically reacted and are completely buffered.
• the preparation of the cosmetic powders according to the invention can be carried out as dry blend.
• polyamide powder and buffer system are used as solids.
• the buffer system can either be ground on its own and then mixed with the polyamide fine powder, or the buffer system and polyamide powder are mixed together and then ground and sifted together.
• a further preparation process includes adding a buffer solution to the polyamide powder and then freeing it together with the polyamide from the solvent. This results in a particularly uniform distribution of the buffer system in the polyamide particle, which is particularly suitable for porous precipitated powders.
• the process is preferably integrated into the drying step of the precipitation process, but can also be carried out subsequently on a dry fine powder.
• the pH of the polyamide powder is determined in each case in suspension of 1 g of powder in 100 ml of distilled water. After stirring for 24 h, the incorporated acids and/or bases have dissolved out of the polyamide. The pH is determined using a calibrated pH electrode. Results are summarized in table 1.
• the present invention also provides cosmetic compositions containing the polyamide powders having the pH as described herein.
• These cosmetic compositions will also include one or more cosmetically acceptable carriers, fragrances, pigments, fillers, and other common ingredients used in cosmetics, such as, emulsifiers, polymers, surfactants, conditioning agents, humectants, sunscreens, etc.
• cosmetically acceptable carriers such as, emulsifiers, polymers, surfactants, conditioning agents, humectants, sunscreens, etc.
• the jacket temperature is then reduced to 124° C., 60 g of phosphoric acid are added as crystallization auxiliary and, with continuous removal of the ethanol by distillation, the internal temperature is brought to 125° C. with stirring at a cooling rate of 25 K/h. From now on, at the same cooling rate, the jacket temperature is maintained at 2 K-3 K below the internal temperature until, at 109° C., precipitation, recognizable from the evolution of heat, starts. Distilling off ethanol ensures that the internal temperature does not exceed 109.5° C. After about 20 minutes the internal temperature drops, which indicates the end of the precipitation. Further distillation and cooling via the jacket brings the temperature of the suspension to 45° C. and the suspension is then transferred to a dryer. The ethanol is distilled off at 70° C./400 mbar, and the residue is then after-dried at 20 mbar/85° C. for 3 hours.
• the desired fine fractions are separated off by repeated screening and sifting corresponding to their average particle diameter.
• a round flask is charged, under protective gas (argon), with 300 ml of dry decalin.
• 80° C. 80 g of laurolactam and 3 g of N,N′-ethylenediaminebisoleamide are dissolved with stirring (600 rpm), and 400 mg of silicon dioxide are added as nucleating agent.
• Traces of water are removed from the reaction mixture by distilling off about 10% of the solvent under reduced pressure at 120 to 130° C.
• 175 mg of sodium hydride are added (Fluka, about 60% strength in oil).
• the reaction mixture is kept for a further 30 minutes at 110° C., then cooled at 0.2 K/min to 100° C.
• the desired fine fractions are separated off according to their average particle diameter by repeated screening and sifting.
• the desired fine fractions are separated off according to their average particle diameter by repeated screening and sifting.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Epidemiology (AREA)
• Birds (AREA)
• Polymers & Plastics (AREA)
• Medicinal Chemistry (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Organic Chemistry (AREA)
• Dermatology (AREA)
• Emergency Medicine (AREA)
• Cosmetics (AREA)
• Polyamides (AREA)
• Compositions Of Macromolecular Compounds (AREA)
• Processes Of Treating Macromolecular Substances (AREA)

Priority Applications (1)

Applications Claiming Priority (2)

Related Child Applications (1)

Publications (1)

Family

ID=7708938

Family Applications (2)

Family Applications After (1)

Country Status (15)

Cited By (23)

Families Citing this family (5)

Citations (46)

Family Cites Families (13)

• 2001
  • 2001-12-12 DE DE10161038A patent/DE10161038A1/de not_active Ceased
• 2002
  • 2002-10-19 AT AT02023443T patent/ATE348852T1/de not_active IP Right Cessation
  • 2002-10-19 DE DE50209000T patent/DE50209000D1/de not_active Expired - Lifetime
  • 2002-10-19 EP EP02023443A patent/EP1319681B2/de not_active Expired - Lifetime
  • 2002-10-23 TW TW091124493A patent/TWI227250B/zh active
  • 2002-11-28 MX MXPA02011787A patent/MXPA02011787A/es unknown
  • 2002-12-02 SK SK1694-2002A patent/SK16942002A3/sk unknown
  • 2002-12-09 PL PL02357632A patent/PL357632A1/xx not_active Application Discontinuation
  • 2002-12-10 BR BR0205161-3A patent/BR0205161A/pt not_active IP Right Cessation
  • 2002-12-10 CA CA2413767A patent/CA2413767C/en not_active Expired - Lifetime
  • 2002-12-10 JP JP2002358375A patent/JP4252296B2/ja not_active Expired - Lifetime
  • 2002-12-10 RU RU2002133059/15A patent/RU2002133059A/ru not_active Application Discontinuation
  • 2002-12-10 KR KR1020020078121A patent/KR100956272B1/ko not_active Expired - Lifetime
  • 2002-12-11 HU HU0204302A patent/HUP0204302A3/hu unknown
  • 2002-12-11 CN CNB021560455A patent/CN100374103C/zh not_active Expired - Lifetime
  • 2002-12-12 US US10/317,122 patent/US20030114636A1/en not_active Abandoned
• 2008
  • 2008-07-15 US US12/173,382 patent/US8293279B2/en not_active Expired - Fee Related

Patent Citations (48)

Also Published As

Similar Documents

Legal Events